Lynx, Norlase’s pattern scanning laser indirect ophthalmoscope, commercially launched with both FDA 510(k) clearance and a CE mark, according to a press release. The ophthalmoscope, which includes an ...

The company states LYNX is the world’s first and only pattern scanning laser indirect ophthalmoscope and is battery-powered ...

BALLERUP, Denmark and REDWOOD CITY, Calif., Jan. 27, 2025 /PRNewswire/ -- Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, today announced the ...

VMT Scientific, Inc. engages in the design, development, testing, and patenting of medical technologies for use in tissue histogenesis. It develops VasCir system, a noninvasive method of assisting ...

China's electric scooter market is booming while customers in Europe look for transport alternatives. Vmoto, an ASX-listed company, is chasing a slice of the action. VMoto has struck a deal with ...

The reason I say that is that...number 1, the technique is challenging to learn. There is a steep learning curve in order to become good in ophthalmoscopy,” he explained. “Number 2, there are lots and ...

The revolutionary PanOptic provides easy entry into the eye, together with a wider field of view to more easily observe conditions such as hypertension, diabetic retinopathy, and papilledema.

It operates primarily in the US. Perspective Therapeutics is headquartered in Richland, Washington, the US. For a complete picture of VMT-01’s drug-specific PTSR and LoA scores, buy the report here.